Tests

1st tests to order

bile acids

Test
Result
Test

Ordered for any pregnant women with pruritus and no identifiable rash other than excoriations.

Nonfasting total serum bile acid concentrations are recommended to identify peak concentrations, as these are also associated with adverse perinatal outcomes.

There is a marked diurnal variation in bile acid concentrations, with post-prandial elevation, so measurement of nonfasting concentrations can be clinically useful, as the peak serum bile acid concentration is associated with the risk of adverse pregnancy outcome.[2][84][85] Nonfasting bile acid concentrations in the third trimester of uncomplicated pregnancies are higher than laboratory reference ranges, which typically vary between 6 and 15 micromol/L. Using the upper limit of the reference range of 19 micromol/L for normal pregnancy to define ICP was not demonstrated to impact the risk of serious adverse perinatal outcomes in women with mild ICP whose nonfasting peak bile acid concentration was below this concentration.[86]

Bile acid elevations may occur weeks after the onset of pruritus, so regular repeat testing is recommended if symptoms persist. For disease stratification, guidelines suggest monitoring every 1 to 3 weeks, with at least weekly monitoring from 32 gestational weeks given the likely impact on timing of birth and management if severe disease is identified.[79]

Result

laboratory-specific upper end of the normal range, typically ≥10 micromol/L and <40 micromol/L (mild), ≥40 micromol/L and <100 micromol/L (moderate), and ≥100 micromol/L (severe); in nonfasting samples, 19 micromol/L is used as the lower diagnostic threshold

liver function tests

Test
Result
Test

Ordered for any pregnant woman with pruritus to determine degree of liver impairment, although elevations are not required for diagnosis. Weekly testing is recommended from 32 gestational weeks to monitor severity and progress of the disease.[79]​ Testing is approximately every 2 weeks before this gestation.

A minority of women with ICP experience hyperbilirubinemia.[10] If bilirubin elevation is marked or persistent, consider investigations to identify the cause.[79]

Result

pregnancy-specific reference ranges should be used; third trimester ranges are alanine aminotransferase 6-32 IU/L, aspartate aminotransferase 11-30 IU/L, bilirubin 0.18 to 0.82 mg/dL, gamma-glutamyl transferase 3-41 IU/L, alkaline phosphatase 133-418 IU/L

Tests to consider

coagulation profile

Test
Result
Test

Recommended for any pregnant woman with symptomatic steatorrhea.

Vitamin K malabsorption may occur in women with steatorrhea, and this subgroup of women with ICP are likely to benefit from prenatal vitamin K supplementation.

Result

normal or prolonged prothrombin time

hepatitis C virology

Test
Result
Test

There is increased incidence of ICP in those with hepatitis C-induced hepatocellular damage. Performed to exclude hepatitis C.

Result

positive for hepatitis C infection

liver and biliary tract ultrasound

Test
Result
Test

Commonly performed to exclude coexistent liver and biliary tree pathology, particularly if liver dysfunction is particularly elevated or persists postpartum.

Result

ICP has no defined ultrasound features, although gallstones and biliary sludge are commonly seen

complete blood count

Test
Result
Test

Anemia is a prominent feature of liver disease. A complete blood count excludes anemia as an alternative cause of pruritus.

Result

in pregnant women, a hemoglobin level of <11 g/dL in the first trimester or <10.5 g/dL in the second and third trimesters; postpartum, a hemoglobin level <10 g/dL indicates anemia

autoantibody tests

Test
Result
Test

A liver autoimmune screen can be performed to identify antibodies associated with autoimmune liver disease. These include antismooth muscle and antimitochondrial antibodies.

Result

negative for liver-related autoantibodies

Use of this content is subject to our disclaimer